GEM 132Alternative Names: Gene Expression Modulator 132
Latest Information Update: 01 Apr 2008
At a glance
- Originator Idera Pharmaceuticals
- Class Antisense DNA; Antivirals
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Cytomegalovirus infections; Cytomegalovirus retinitis